CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 59 enrolled
Drug / intervention
Inhaled primatene will be given as a breathing treatment +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00435994
NCT00435994N/ACompleted

Assessment of Airway Obstruction in Infants With Lower Respiratory Infections

Indiana University·interventional·Posted Feb 16, 2007·Updated Jun 1, 2016

In Brief

A clinical study evaluating Inhaled primatene will be given as a breathing treatment and Nasal Washing for Bronchiolitis and Respiratory Syncytial Virus Infections. Completed, enrolled 59 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate how two different aerosol medications may improve airway function in infants with respiratory illness. We are using two different medications and comparing the difference in lung function after each medication. We will also be taking a nasal wash sample for VEGF. We will be using this in comparing how infants respond to the aerosol medications as well. We hope to help standardize medications used for infants with bronchiolitis and RSV.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 16, 2007
Enrollment StartDec 1, 2003
Primary CompletionMar 1, 2009
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 19.4 years ago

Interventions

Inhaled primatene will be given as a breathing treatmentdrug

While the research subject is sedated an inhaled mist of primatene mist will be given to the patient.

Nasal Washingother

1-3 mls of normal saline will be instilled into the infant's nose and then aspirated to obtain the nasal fluid, which will be analyzed for VEGF level by ELISA and viral antigens by immunoflourescence